Ite A Offringa
Overview
Explore the profile of Ite A Offringa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
St Pierre L, Berhan A, Sung E, Alvarez J, Wang H, Ji Y, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Nov;
1871(3):167572.
PMID: 39547519
Idiopathic pulmonary fibrosis (IPF) is a lethal progressive lung disease urgently needing new therapies. Current treatments only delay disease progression, leaving lung transplant as the sole remaining option. Recent studies...
2.
Gregory M, Ofosu-Asante K, Lazarte J, Puente P, Tawfeeq N, Belony N, et al.
PLoS One
. 2024 Oct;
19(10):e0312563.
PMID: 39436906
KRAS mutations are the most common oncogenic mutations in lung adenocarcinoma in Black Americans. Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed...
3.
Ren B, Chiaravalloti T, Belony N, Romero D, Chai W, Leon C, et al.
Biodes Manuf
. 2024 Jul;
6(6):646-660.
PMID: 38993804
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been spreading globally and threatening public health. Advanced models that recapitulate the architecture and functioning...
4.
Mochona B, Redda K, Offringa I, Allen J, Carpten J, Stern M, et al.
J Cancer Educ
. 2024 Mar;
39(4):405-412.
PMID: 38520478
In our previous publication, we reported a framework to develop an undergraduate cancer research training program at Florida A&M University (FAMU) under the umbrella of the Florida-California Cancer Research, Education,...
5.
Leon C, Manley Jr E, Neely A, Castillo J, Ramos Correa M, Velarde D, et al.
Front Oncol
. 2023 Nov;
13():1187585.
PMID: 38023251
Lung cancer is the leading cause of cancer death in the United States and worldwide, and a major source of cancer health disparities. Lung cancer cell lines provide key models...
6.
Reams R, Odedina F, Carpten J, Redda K, Stern M, Krieger J, et al.
Cancer Control
. 2023 Sep;
30:10732748231197878.
PMID: 37703814
Introduction: The Florida-California Cancer Research, Education, and Engagement (CaRE) Health Equity Center is a triad partnership committed to increasing institutional capacity for cancer disparity research, the diversity of the cancer...
7.
Tran E, Shi T, Li X, Chowdhury A, Jiang D, Liu Y, et al.
iScience
. 2022 Feb;
25(2):103780.
PMID: 35169685
Many acute and chronic diseases affect the distal lung alveoli. Alveolar epithelial cell (AEC) lines are needed to better model these diseases. We used de-identified human remnant transplant lungs to...
8.
Johnson C, Mullen D, Selamat S, Campan M, Offringa I, Marconett C
Int J Environ Res Public Health
. 2022 Jan;
19(1).
PMID: 35010676
Lung cancer is the leading cause of cancer-related death. Tobacco exposure is associated with 80-90% of lung cancer cases. The sulfotransferase modifies xenobiotic compounds to enhance secretion but can also...
9.
Rangel D, Dubeau L, Park R, Chan P, Ha D, Pulido M, et al.
Oncogene
. 2021 May;
40(20):3624-3632.
PMID: 33931739
Lung cancer is the leading cause of cancer mortality worldwide and KRAS is the most commonly mutated gene in lung adenocarcinoma (LUAD). The 78-kDa glucose-regulated protein GRP78/BiP is a key...
10.
Horie M, Castaldi A, Sunohara M, Wang H, Ji Y, Liu Y, et al.
Cells
. 2020 Nov;
9(11).
PMID: 33187367
Molecular and functional characterization of alveolar epithelial type I (AT1) cells has been challenging due to difficulty in isolating sufficient numbers of viable cells. Here we performed single-cell RNA-sequencing (scRNA-seq)...